SLAMF7 Polyclonal Antibody

SLAMF7 Polyclonal Antibody

The SLAMF7 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of SLAMF7 protein expression. This antibody is produced using advanced techniques and rigorous quality control measures to ensure optimal performance and reproducibility.

SLAMF7, also known as CD319 or CS1, is a cell surface glycoprotein that belongs to the signaling lymphocytic activation molecule (SLAM) family. It is primarily expressed on natural killer (NK) cells, plasma cells, and a subset of T cells. SLAMF7 plays a crucial role in immune cell activation, regulation, and cytotoxicity.

The SLAMF7 Polyclonal Antibody exhibits exceptional sensitivity and specificity, enabling accurate detection and quantification of SLAMF7 protein levels in various biological samples. It has been extensively validated for use in immunohistochemistry (IHC), immunofluorescence (IF), western blotting (WB), and flow cytometry (FC) applications.

This antibody demonstrates excellent performance in both research and clinical settings, making it an invaluable tool for studying SLAMF7-related processes and diseases. Its high affinity and low background ensure reliable and reproducible results, facilitating precise and meaningful data interpretation.

The SLAMF7 Polyclonal Antibody is supplied as a liquid formulation in a convenient size, allowing for easy handling and storage. It is provided in a ready-to-use format, eliminating the need for time-consuming and complex preparation steps.

Choose the SLAMF7 Polyclonal Antibody for its exceptional quality, reliability, and versatility. With this antibody, you can confidently explore the intricate mechanisms and functions associated with SLAMF7, advancing your research and contributing to scientific advancements in the field of immunology.